Cargando…
MSC Pretreatment for Improved Transplantation Viability Results in Improved Ventricular Function in Infarcted Hearts
Many clinical studies utilizing MSCs (mesenchymal stem cells, mesenchymal stromal cells, or multipotential stromal cells) are underway in multiple clinical settings; however, the ideal approach to prepare these cells in vitro and to deliver them to injury sites in vivo with maximal effectiveness rem...
Autores principales: | Pittenger, Mark F., Eghtesad, Saman, Sanchez, Pablo G., Liu, Xiaoyan, Wu, Zhongjun, Chen, Ling, Griffith, Bartley P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775864/ https://www.ncbi.nlm.nih.gov/pubmed/35054878 http://dx.doi.org/10.3390/ijms23020694 |
Ejemplares similares
-
Oxidative Stress, DNA Damage and Repair in Heart Failure Patients after Implantation of Continuous Flow Left Ventricular Assist Devices
por: Mondal, Nandan Kumar, et al.
Publicado: (2013) -
Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment
por: Hayashita-Kinoh, Hiromi, et al.
Publicado: (2020) -
Imaging of MSC transplantation in neuroscience
por: Filippi, Miriam, et al.
Publicado: (2017) -
Pretreatment with melatonin improves ovarian tissue cryopreservation for transplantation
por: Shiroma, Marcos Eiji, et al.
Publicado: (2021) -
Indexed donor cardiac output for improved size matching in heart transplantation: A United Network for Organ Sharing database analysis
por: Pasrija, Chetan, et al.
Publicado: (2023)